✦ LIBER ✦

A Risk-Benefit Assessment of Interleukin-2 as an Adjunct to Antiviral Therapy in HIV Infection

✍ Scribed by Dr Stephen C. Piscitelli, Niranjan Bhat, Alice Pau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of oral zinc supplementation as

✍ N. Fabris 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Benefit of oral zinc supplementation as

✍ E. Mocchegiani; S. Veccia; F. Ancarani; G. Scalise; N. Fabris 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 715 KB

Economic assessment of troglitazone as a

✍ J. Jaime Caro; Wendy S. Klittich; Gabriel Raggio; Patricia L. Kavanagh; Judith A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 882 KB

Evaluation of an intracellular pharmacok

✍ Diane M. Cappelletty 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Assessment of chloroquine as a modulator

✍ Routy, J-P; Angel, JB; Patel, M; Kanagaratham, C; Radzioch, D; Kema, I; Gilmore, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

PCV21 A BENEFIT-RISK ASSESSMENT OF USING

✍ GF Guzauskas; D Veenstra; D Hughes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB